Catalyst Wire Dossier Catalyst Wire Dossier

Griseofulvin

GRISEOFULVIN · Actavis Pharma, Inc.
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for Griseofulvin, covering 2007-02-21 to 2020-12-28. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence (BE) Study of Test Griseofulvin 500 Milligram (mg) Tablets Versus Reference and Dose Proportionality Study of Test Griseofulvin 250 mg and 500 mg Tablets Under Fed Conditions [Phase 1]

See pricing